Search by Drug Name or NDC
NDC 65162-0664-90 Ranitidine 15 mg/mL Details
Ranitidine 15 mg/mL
Ranitidine is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is RANITIDINE HYDROCHLORIDE.
Product Information
| NDC | 65162-0664 |
|---|---|
| Product ID | 65162-664_917462a4-6f47-4e77-8961-ccdb02412647 |
| Associated GPIs | 49200020101210 |
| GCN Sequence Number | 011672 |
| GCN Sequence Number Description | ranitidine HCl SYRUP 15 MG/ML ORAL |
| HIC3 | Z2D |
| HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
| GCN | 12090 |
| HICL Sequence Number | 004520 |
| HICL Sequence Number Description | RANITIDINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Ranitidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ranitidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 15 |
| Active Ingredient Units | mg/mL |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078312 |
| Listing Certified Through | 2023-12-31 |
Package
NDC 65162-0664-90 (65162066490)
| NDC Package Code | 65162-664-90 |
|---|---|
| Billing NDC | 65162066490 |
| Package | 473 mL in 1 BOTTLE (65162-664-90) |
| Marketing Start Date | 2010-03-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |